Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

Turning AI challenges into real effects – together

How we can transform complex challenges in healthcare and pharmaceuticals into real impact through responsible AI, strong collaboration, and digital leadership.

The Missing Layer in Enterprise RAG: Knowing When Not to Trust Your AI

How uncertainty estimation empowers RAG pipelines to measure their own doubt and understand their own limitations for true production-grade reliability.

Article

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Event

Events

Agentic Economy Forum

One day, one room, and the people actually building the agentic economy. October 14, 2026

Article

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.